EXECUTIVE SUMMARY - Asmacure, Ltée: A New Mechanism for the Treatment for Asthma
Executive Summary: Martin Driscoll, CEO of Asmacure, talks about his company’s unique, yet practical approach to treating asthma and its core symptoms.
FORMULATION SELECTION - Amorphous Dispersions & Other Tools for Drug Discovery Formulation Support
Corey J. Bloom, PhD, and David K. Lyon, PhD, describe broadly applicable formulation approaches and biomodeling tools that have been successfully used to improve the solubility and in vivo performance of lowsolubility compounds.
IMPURITIES DETECTION - Impurities Detection in Pharmaceuticals
Kevin P. Menard, PhD, focuses on the detection of residual solvents from processing and small levels of contaminates leached from containers.
MANAGEMENT INSIGHT - Listening to the Voice of Inexperience
Derek G. Hennecke continues with part 3 of a new 6-part series offering an overview of this year’s best business books with insights into what they can teach the Pharma industry.
THERAPEUTIC FOCUS: Sufentanil NanoTab Technology: Revolutionizing Patient-Controlled Analgesia
Pamela P. Palmer, MD, PhD; examines how AcelRx’s system can deliver the benefits of PCA in terms of patient pain relief and satisfaction while reducing both drug and device safety risks as well as the overall complexity of pain management, thus reducing both drug and device safety risks as well as the overall complexity of pain management, thus reducing the cost burden on the healthcare system.
SPECIAL REPORT - Outsourcing Formulation Development and Manufacturing: An Early Approach Saves Time and Money
In this Special Report, Contributor Cindy H. Dubin asks many of the leading companies in this sector what challenges pharma currently faces in formulation and manufacturing and how they, as third-party providers, are helping to alleviate those burdens.
EXECUTIVE INTERVIEW - Agere: Solubilization: Accessing Broader Chemistries by Integrating Fundamental Science With Automation for Greater Predictability
Drug Development Executive: Marshall Crew, President & CEO of Agere, discusses how the company is taking a different approach that leverages expertise, but relies heavily on the principles of physical chemistry to enable automation.
FORMULATION DEVELOPMENT - Bioavailability Enhancement Strategies & Opportunities
Frost & Sullivan Analyst Ruplekha Choudhurie reviews some BA approaches that are being developed by a number of companies that can mitigate the biological, physical, and chemical barriers for effective delivery of poorly soluble and permeable drugs.
MANAGEMENT INSIGHT - Business Lessons From the Salamander
Derek G. Hennecke continues with part 2 on a new 6-part series offering an overview of this year’s best business books with insights into what they can teach the Pharma industry.
SPECIAL FEATURE - Analytical Instrumentation Gets Faster, Smaller, and Easier to Use
Contributor Cindy H. Dubin learns that one doesn’t have to be a rocket scientist to use analytical instrumentation. Three leading players in the market showcase their products, all aimed at making analysis easier and faster.
EXECUTIVE INTERVIEW - AAIPharma: Making the CDMO a One-Stop-Shop for Manufacturing, Development & Analytical Services
Drug Development Executive: Patrick Walsh, CEO, and Board Director of AAIPharma Services Corp., talks about the role of a CDMO in today’s pharma and biotech space, why companies may choose to partner with a CDMO, and how the company has managed to maintain a leading position in the market.
DRUG DEVICES - Intranasal Saline: Can a Spray Per Day Keep the Doctor Away?
Degenhard Marx, PhD, and Georges Bouille provide an overview and discussion of the benefits of using intranasal saline, and a range of different devices on the market allowing administration into the nose.
CONTRACT SERVICES - Maximizing Yield in Transdermal Manufacturing
James Fenton says that while the challenges presented by manufacturing pain management products can be significant for some manufacturers, for the right manufacturer, pain management products can present an ideal opportunity.
DELIVERY DEVICES - The New Industry Paradigm for Prefilled Success
Alan Shortall indicates that following a period of relative industry stability defined by peripheral innovation, a converging series of external and internal forces are set to reshape the prefilled syringe industry so that it will better serve the emerging needs of pharmaceutical companies, patients, and other stakeholders across the continuum of care.
DRUG DELIVERY - Oral Delivery of Peptides by Peptelligence Technology
William Stern, PhD; Nozer Mehta, PhD; and Stephen Carl, PhD; review a highly developed, clinically proven platform technology that enables the oral delivery of peptides, overcoming the hurdles inherent to oral peptide delivery.
Adhesives Research, Inc. : Focused Product Development Process Results in Successful Custom Pressure-Sensitive Adhesive Solutions for TDDS
A new level of commitment is required of adhesives suppliers by Pharmaceutical companies searching for unique pressure-sensitive adhesive systems and coated products for their transdermal…
Lactose in Pharmaceutical Applications
INTRODUCTIONLactose is a naturally occurring simple carbohydrate, or sugar, found only in the milk of mammals. For this reason, it is also commonly referred to…
